U.S. Federal Trade Commission Clears Teva Pharmaceutical Industries Limited And IVAX Corporation Merger; Closing Scheduled For January 26, 2006

Published: Jan 23, 2006

JERUSALEM & MIAMI--(BUSINESS WIRE)--Jan. 23, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and IVAX Corporation (AMEX: IVX) announced today that the U.S. Federal Trade Commission ("FTC") has accepted the proposed consent order for public comment and granted early termination of the Hart Scott Rodino waiting period, thereby permitting the parties to close the transaction.

Back to news